Filing metadata

Accession number
0000950170-24-074855
Form type
Form 3
Filer
Fulcrum Therapeutics, Inc.
CIK
CIK 1680581
Filed
Jun 18, 2024
Reporting period
Jun 17, 2024
Description
Initial ownership

Explore SEC Filings Hub